1. Background
The Association of Southeast Asian Nations (ASEAN) was established in 1967 and currently comprises 10 member states, including Indonesia, the Philippines, Malaysia, Vietnam, Thailand, Singapore, Brunei, Laos, Cambodia, and Myanmar.
As Southeast Asia’s healthcare sector continues to expand, ASEAN has become one of the most attractive destinations for medical device manufacturers seeking international market access.
Although ASEAN member states have largely aligned their medical device classification systems under the ASEAN Medical Device Directive (AMDD), regulatory approval pathways, review requirements, and market access procedures still vary significantly from country to country.
2. Market Access Pathways
Indonesia
Indonesia does not currently offer an official expedited review pathway. However, registration timelines are generally efficient once complete documentation has been submitted.
Manufacturers are required to provide comprehensive technical documentation, and higher-risk devices may require additional clinical evaluation evidence. Indonesia generally allows only one authorized representative to be linked to a medical device registration certificate. Regulatory authorities also impose strict requirements regarding Bahasa Indonesia labeling and product conformity declarations.
Vietnam
Vietnam adopts a notification-based system for Class A and Class B medical devices. Devices holding approvals from recognized reference countries can often obtain approval within a relatively short timeframe.
For higher-risk devices, manufacturers must obtain a Market Authorization (MA) License, which has long-term validity. One notable advantage is that devices approved by recognized reference authorities may qualify for a simplified review process with reduced technical assessment requirements. Vietnam currently recognizes several foreign regulatory authorities, including China’s NMPA, enabling eligible products to benefit from accelerated registration pathways.
Malaysia
Malaysia applies a four-tier risk classification system (Class A–D) that is highly aligned with the AMDD framework.
Class A devices may follow a self-declaration route, subject to administrative review by the Medical Device Authority (MDA). For Class B, C, and D devices, manufacturers must first obtain conformity assessment approval from an MDA-recognized Conformity Assessment Body (CAB) before submitting a registration application to MDA.
Malaysia also provides facilitated pathways for devices approved by reference regulatory authorities such as Australia, the European Union, the United States, and Singapore. Registered devices are generally granted a validity period of five years.
Singapore
Class A medical devices are generally exempt from registration and may enter the market through a listing process.
For Class B, C, and D devices, manufacturers must submit applications to the Health Sciences Authority (HSA). To accommodate different regulatory situations, HSA offers multiple registration routes, including full evaluation, abridged evaluation, expedited evaluation, and priority review.
Devices already approved by recognized reference agencies, such as those in Australia, Canada, Japan, the United States, or the European Union, may qualify for simplified or accelerated review pathways. Devices without prior approval from any reference authority may still be registered through full or priority evaluation routes.
Thailand
Thailand categorizes medical devices into different regulatory groups. Class 1 devices generally follow a listing process, while Class 2 and Class 3 devices require notification approval. Class 4 devices must obtain a formal medical device license and undergo technical review by the Thai regulatory authority.
Thailand offers a reliance pathway for devices approved in recognized reference markets, provided the device has been commercially marketed for at least one year. However, certain device categories—including contact lenses, HIV diagnostic kits, and several other specified products—are excluded from this pathway and must undergo full registration when entering the Thai market for the first time.
Philippines
Class A medical devices require a Certificate of Medical Device Notification (CMDN), while Class B, C, and D devices require a Certificate of Medical Device Registration (CMDR), also known as a Certificate of Product Registration (CPR), before they can be imported and marketed in the Philippines.
Registrations are generally valid for five years. The Philippines recognizes approvals issued by ASEAN member states and may offer accelerated review pathways for equivalent devices already approved within the ASEAN region. However, any significant adverse regulatory findings or safety concerns reported by other jurisdictions may affect eligibility for expedited review.
3. Conclusion
While ASEAN member states have largely harmonized their medical device classification systems, substantial differences remain in registration pathways, review procedures, and local compliance requirements.
For manufacturers seeking to enter multiple ASEAN markets, understanding the relationship between device classification, regulatory review depth, and country-specific compliance obligations is essential for developing an effective and efficient market access strategy.
A well-planned ASEAN regulatory strategy can significantly reduce approval timelines, optimize compliance costs, and accelerate commercial expansion across Southeast Asia.